Metabolic and redox barriers in the skin exposed to drugs and xenobiotics

References

• Korkina L, Pastore S. The role of redox regulation in the normal physiology and inflammatory diseases of skin. Front Biosci. 2009;1:123–141.
   Google Scholar
• Kaplan DH, Igyarto BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol. 2012;12:114–24.
   PubMed Web of Science ®Google Scholar
• Cross CE, van der Vliet A, Louie S, et al. Oxidative stress and antioxidants at biosurfaces: plants, skin, and respiratory tract surfaces. Environ Health Perspect. 1998;106(suppl. 5):1241–1251.
   PubMed Web of Science ®Google Scholar
• Wondrak GT, Jacobson MK, Jacobson EL. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photo protection. Photochem Photobiol Sci. 2006;5:215–237.
   PubMed Web of Science ®Google Scholar
• Park SL, Justiniano R, Williams JD, et al. The tryptophan-derived endogenous Aryl hydrocarbon receptor ligand 6-Formylindolo[3,2-b]Carbazole Is a Nanomolar UVA photosensitizer in epidermal keratinocytes. J Invest Dermatol. 2015;135:1649–1658.
   PubMed Web of Science ®Google Scholar
• Hibbert SA, Watson REB, Gibbs NK, et al. A potential role for endogenous proteins as sacrificial sunscreens and antioxidants in human tissues. Redox Biol. 2015;5:101–13.
   PubMed Web of Science ®Google Scholar
• Kawanishi S, Hiraku Y. Oxidants and antioxidants in cutaneous biology. Curr Probl Dermatol. 2001;29:74–82.
   PubMedGoogle Scholar
• Korkina L, De Luca C, Pastore S. Plant polyphenols and human skin: friends or foes. Ann NY Acad Sci. 2012;1259:77–86.
   PubMed Web of Science ®Google Scholar
• Kwon MJ, Han J, Kim BH, et al. Superoxide dismutase 3 suppresses hyaluronic acid fragments mediated skin inflammation by inhibition of toll-like receptor 4 signaling pathway: superoxide dismutase 3 inhibits reactive oxygen species-induced trafficking of toll-like receptor 4 to lipid rafts. Antioxid Redox Signal. 2012;16:297–313.
   PubMed Web of Science ®Google Scholar
• Packer L, Valacchi G. Antioxidants and the response of skin to oxidative stress: vitamin E as a key indicator. Skin Pharmacol Appl Skin Physiol. 2002;15:282–290.
   PubMedGoogle Scholar
• Holley AK, Xu Y, Noel T, et al. Manganese superoxide dismutase-mediated inside-out signaling in HaCaT human keratinocytes and SKH-1 mouse skin. Antioxid Redox Signal. 2014;20:2347–2360.
   PubMed Web of Science ®Google Scholar
• Thiele J, Barland CO, Ghadially R, et al. Permeability and antioxidant barriers in aged skin. In: Gilchrest B, Krutmann J, Eds. Skin aging. Berlin, Germany: Springer; 2006.
   Google Scholar
• Slominski AT, Zmijewski MA, Semak I, et al. Cytochromes P450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem. 2014;14:77–96.
   PubMed Web of Science ®Google Scholar
• Slominski AT, Kleszczynski K, Semak I, et al. Local melatoninergic system as the protector of skin integrity. Int J Mol Sci. 2014;15:17705–17732.
   PubMed Web of Science ®Google Scholar
• Kim TK, Kleszczynski K, Janjetovic Z, et al. Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. Faseb J. 2013;27:2742–2755.
   PubMed Web of Science ®Google Scholar
• Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 2005;224:171–184.
   PubMed Web of Science ®Google Scholar
• Pelle E, Mammone T, Maes D, et al. Keratinocytes act as a source of reactive oxygen species by transferring hydrogen peroxide to melanocytes. J Invest Dermatol. 2005;124:793–797.
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signalling. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1005- L28.
   PubMed Web of Science ®Google Scholar
• Wu D, Cederbaum AI. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol Appl Pharmacol. 2005;207(2 Suppl):70–76.
   PubMedGoogle Scholar
• Soneja A, Drewes M, Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep. 2005;57 Suppl:108–119.
   PubMed Web of Science ®Google Scholar
• De Luca C, Valacchi G. Surface lipids as multifunctional mediators of skin responses to environmental stimuli. Mediators Inflamm. 2010;2010:321494.
   PubMed Web of Science ®Google Scholar
• Niki E. Do antioxidants impair signaling by reactive oxigen sepcies and lipid oxidation products? FEBS Lett. 2012;586:3767–70.
   PubMed Web of Science ®Google Scholar
• Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 2009;47:469–484.
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Ann Rev Pharmacol Toxicol. 1999;39:361–398.
   PubMed Web of Science ®Google Scholar
• Cole SPC. Deeley RG Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. BioEssays. 1998;20:931–940.
   PubMed Web of Science ®Google Scholar
• Baron JM, Holler D, Schiffer R, et al. Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J Invest Dermatol. 2001;116:541–80.
   PubMed Web of Science ®Google Scholar
• Sarkadi B, Ozvegy-Laszka C, Nemet K, et al. ABCG2- A transporter for all seasons. FEBS Lett. 2004;567:116–120.
   PubMed Web of Science ®Google Scholar
• Cort A, Ozben T, Saso L, et al. Redox control of multi-drug resistance and its possible modulation by antioxidants. Oxid Med Cell Longevity. 2016;2016:Article ID 4251912, 17 pages doi:10.1155/2016/4251912.
   PubMedGoogle Scholar
• Gundert-Remy U, Bernauer U, Blomeke B, et al. Extrahepatic metabolism at the body’s internal-external interfaces. Drug Metab Rev. 2014;46:291–324.
   PubMed Web of Science ®Google Scholar
• Oesch F, Fabian E, Guth K, et al. Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea, and in human skin models. Arch Toxicol. 2014;88:2135–9031.
   PubMed Web of Science ®Google Scholar
• Dammak I, Boudaya S, Ben Abdallah F, et al. Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. International Journal of Dermatology. 2009;48:476–480.
   PubMed Web of Science ®Google Scholar
• Neis MM, Wendel A, Wiederholt T, et al. Expression and induction of cytochrome p450 isoenzymes in human skin equivalents. Skin Pharmacol Physiol. 2010;23:29–39.
   PubMed Web of Science ®Google Scholar
• Wiegand C, Hewitt NJ, Merk HF, et al. Dermal xenobiotic metabolism: a comparison between native human skin, four in vitro skin test systems and a liver system. Skin Pharmacol Physiol. 2014;27:263–275.
   PubMed Web of Science ®Google Scholar
• Modi BG, Neustadter J, Binda E, et al. Langerhans cells facilitate epithelial DNA damagr and squamous cell carcinoma. Science. 2012;335:104–108.
   PubMed Web of Science ®Google Scholar
• van Eijl S, Zhu Z, Cupitt J, et al. Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling. PLoS One. 2012;7:e4172136.
   Web of Science ®Google Scholar
• Seidegård J, Ekström G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ. Health Perspect. 1997;105(Suppl 4):791–799.
   PubMed Web of Science ®Google Scholar
• Götz C, Pfeiffer R, Tigges J, et al. Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol. 2012;21:358–363.
   PubMed Web of Science ®Google Scholar
• Swanson HI. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem Biol Interact. 2004;149:69–79.
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Matsui MS, Mukhtar H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J Invest Dermatol. 2000;114:328–333.
   PubMed Web of Science ®Google Scholar
• Pavek P, Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab. 2008;9:129–143.
   PubMed Web of Science ®Google Scholar
• Rannug A, Fritsche E. The aryl hydrocarbon receptor and light. Biol Chem. 2006;387:1149–1157.
   PubMed Web of Science ®Google Scholar
• Wincent E, Amini N, Luecke S, et al The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P450I substrate 6-formylindolo[3,2-b]carbazole is present in humans. J Biol Chem. 2009;284:2690–2696.
   PubMed Web of Science ®Google Scholar
• Potapovich AI, Lulli D, Fidanza P, et al. Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFκB and AhR and EGFR–ERK pathway. Toxicol Appl Pharmacol. 2011;255:138–149.
   PubMed Web of Science ®Google Scholar
• Pastore S, Lulli D, Fidanza P, et al. Plant polyphenols regulate chemokine expression and tissue repair in human keratinocytes through interaction with cytoplasmic and nuclear components of epidermal growth factor receptor system. Antioxid Redox Signal. 2012;16:314–328.
   PubMed Web of Science ®Google Scholar
• De Luca C, Scordo MG, Cesareo E, et al. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicol Appl Pharmacol. 2010;248:285–292.
   PubMed Web of Science ®Google Scholar
• Chiaro CR, Patel RD, Perdew GH. 12(R)-hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoic acid [12(R)-HETE], an arachidonic acid derivative, is an activator of the aryl hydrocarbon receptor. Mol Pharmacol. 2008;74:1649–1656.
   PubMed Web of Science ®Google Scholar
• Bergstrom MA, Ott H, Carlsson A, et al. A skin-like cytochrome P450 coctail activates prohaptens to contact allergenic metabolites. J Invest Dermatol. 2007;127:1145–1153.
   PubMed Web of Science ®Google Scholar
• Svensson CK. Biotransformation of drugs in human skin. Drug Metab Dispos. 2009;37:247–53.
   PubMed Web of Science ®Google Scholar
• Roychowdhury S, Vyas PM, Svensson CK. Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells. Drug Metab Dispos. 2007;35:676–681.
   PubMed Web of Science ®Google Scholar
• Vyas PM, Roychowdhury S, Woster PM, et al. Reactive oxygen species generation and its role in the differential toxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes. Biochem Pharmacol. 2005;70:275–286.
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Edwards RJ, Fritsche E, et al. Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations. Toxicol Sci. 2013;133:209–217.
   PubMed Web of Science ®Google Scholar
• Mena S, Ortega A, Estrela JM. Oxidative stress in environmental-induced carcinogenesis. Mut Res Gen Toxicol EnvironMutagenesis. 2009;674:36–44.
   PubMed Web of Science ®Google Scholar
• Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Cur Med Chem. 2005;12:1161–1208.
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56:331–349.
   PubMed Web of Science ®Google Scholar
• Liu XX, Sun CB, Yang TT, et al. Decreased skin-mediated detoxification contributes to oxidative stress and insulin resistance. Exp Diabetes. 2012;2012:128694.
   PubMedGoogle Scholar
• Surh YJ, Kundu JK, Na HK, et al. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemical. J Nutr. 2005;135:2993S–3001S.
   PubMed Web of Science ®Google Scholar
• Pal M, Levin S. Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors. Acta Physiol Sinica. 2015;67:1–18.
   PubMedGoogle Scholar
• Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Rad Biol Med. 2009;47:891–905.
   PubMed Web of Science ®Google Scholar
• Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What’s new? J Eur Acad Dermatol Vener. 2003;17:663–669.
   PubMed Web of Science ®Google Scholar
• Klotz LO, Holbrook NJ, Sies H. UVA and singlet oxygen as inducers of cutaneous signaling events. Cur Probl Dermatol. 2001;29:95–113.
   PubMedGoogle Scholar
• Okayama Y. Oxidative stress in allergic and inflammatory skin diseases. Cur Drug Target-Inflamm Allergy. 2005;4:517–519.
   PubMedGoogle Scholar
• Köhle C, Bock KW. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem Pharmacol. 2007;73:1853–1862.
   PubMed Web of Science ®Google Scholar
• Higgins LG, Hayes JD. Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents. Drug Metab Rev. 2011;43:92–137.
   PubMed Web of Science ®Google Scholar
• Ikuta T, Namiki T, Fujii-Kuriyama Y, et al. AhR protein trafficking and function in the skin. Biochem Pharmacol. 2009;77:588–596.
   PubMed Web of Science ®Google Scholar
• Nguyen LP, Bradfield CA. The search for endogenous activators of aryl hydrocarbon receptor. Chem Res Toxicol. 2008;21:102–116.
   PubMed Web of Science ®Google Scholar
• Stejskalova L, Dvorak Z, Pavek P. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr Drug Metab. 2011;12:198–212.
   PubMed Web of Science ®Google Scholar
• Kostyuk V, Potapovich A, Stancato A, et al. Photo-oxidation products of skin surface squalene mediate metabolic and inflammatory responses to solar UV in human keratinocytes. PLoS One. 2012;7:e44472.
   PubMed Web of Science ®Google Scholar
• Kalthoff S, Ehmer U, Freiberg N, et al. Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10. JBiol Chem. 2010;285:5993–6002.
   PubMed Web of Science ®Google Scholar
• Yeager RL, Reisman SA, Aleksunes LM, et al. Introducing the TCDD-inducible AhR-Nrf2 gene battery. Toxicol Sci. 2009;111:238–246.
   PubMed Web of Science ®Google Scholar
• Haarmann-Stemmann Bothe TH, Abel J. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol. 2009;77:508–520.
   PubMed Web of Science ®Google Scholar
• Ma Q. Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease. Exp Opin Drug Metab Toxicol. 2011;7:1267–93.
   PubMed Web of Science ®Google Scholar
• Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol. 1999;77:13–22.
   Google Scholar
• Ohtake F, Takeyama K, Matsumoto T, et al. Modulation of estrogen receptor signaling by association with the activated dioxin receptor. Nature. 2003;423:545–550.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP, Okey AB, et al. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem. 2004;279:23847–23850.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 2006;6:947–960.
   PubMed Web of Science ®Google Scholar
• Guyot E, Chevallier A, Barouki R, et al. The AhR twist: ligand-dependent AhR signaling and pharmaco- toxicological implications. Drug Discovery Today. 2013;18:479–486.
   PubMed Web of Science ®Google Scholar
• Busbee PB, Busbee M, Rouse M, et al. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr Rev. 2013;71:353–369.
   PubMed Web of Science ®Google Scholar
• Kim SH, Henry EC, Kim DK, et al. Novel compound 2-methyl-2H-pyrazole-3- carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8- TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol. 2006;69:1871–1875.
   PubMed Web of Science ®Google Scholar
• Murray IA, Flaveny CA, DiNatale BC, et al. Antagonism of aryl hydrocarbon receptor signaling by 6,2ʹ,4ʹ-trimethoxyflavone. J Pharm Exper Ther. 2010;332:135–144.
   PubMed Web of Science ®Google Scholar
• Pastore S, Lulli D, Pascarella A, et al. Resveratrol enhances solar UV-induced responses in normal human epidermal keratinocytes. Photochem Photobiol. 2012;88:1522–1530.
   PubMed Web of Science ®Google Scholar
• Nosbaum A, Vocanson M, Rozieres A, et al. Allergic and irritant contact dermatitis. Eur J Dermatol. 2009;19:325–332.
   PubMed Web of Science ®Google Scholar
• Albanesi C, Pastore S. Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs. Cur Drug Metab. 2010;11:210–227.
   PubMed Web of Science ®Google Scholar
• Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 2006;126:2565–2575.
   PubMed Web of Science ®Google Scholar
• Trenam CW, Darbagh AJ, Morris CJ, et al. Skin inflammation induced by reactive oxygen species (ROS): an in vivo model. Br J Dermatol. 1991;125:325–329.
   PubMed Web of Science ®Google Scholar
• Fuchs J, Zollner TM, Kaufmann R, et al. Redox-modulated pathways in inflammatory skin diseases. Free Rad Biol Med. 2001;30:337–353.
   PubMed Web of Science ®Google Scholar
• Senaldi G, Pointaire P, Piguet PF, et al. Protective effect of N-acetylcysteine in hapten-induced irritant and contact hypersensitivity. J Invest Dermatol. 1994;102:934–937.
   PubMed Web of Science ®Google Scholar
• Nordberg J, Zhong L, Holmgren A, et al. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active 22 selenocysteine and its neighboring cysteine residue. J Biol Chem. 1998;273:10835–10842.
   PubMed Web of Science ®Google Scholar
• Kaur S, Zilmer M, Eisen M, et al. Nickel sulphate and epoxy resin: differences in iron status and glutathione redox ration at the time of patch testing. Arch Dermatol Res. 2004;295:517–520.
   PubMed Web of Science ®Google Scholar
• Pickard C, Louafi F, McGuire C, et al. The cutaneous biochemical redox barrier: a component of the innate immune defenses against sensitisation by highly reactive environmental xenobiotics. J Immunol. 2009;183:7576–7584.
   PubMed Web of Science ®Google Scholar
• Anderson C, Hehr A, Robbins R, et al. Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol. 1995;155(3530–37):1995.
   Google Scholar
• Aeby P, Sieber T, Beck H, et al. Sin sensitization to p-phenylenediamine: the diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. J Invest Dermatol. 2009;129:99–109.
   PubMed Web of Science ®Google Scholar
• Haddad JJ. Redox regulation of pro-inflammatory cytokines and IkappaB/NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun. 2002;296:847–856.
   PubMed Web of Science ®Google Scholar
• Ormerod AD, Dwyer CM, Reid A, et al. Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis. Acta Dermatol Vener. 1997;77:436–440.
   PubMed Web of Science ®Google Scholar
• Teixeira MM, Williams TJ, Hellewell PG. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol. 1993;110:1515–1521.
   PubMed Web of Science ®Google Scholar
• Ormerod AD, Copeland P, Hay I, et al. The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. J Invest Dermatol. 1999;113:392–397.
   PubMed Web of Science ®Google Scholar
• Morita H, Hori M, Kitano Y. Modulation of picryl chloride-induced contact hypersensitivity reaction in mice by nitric oxide. J Invest Dermatol. 1996;107:549–552.
   PubMed Web of Science ®Google Scholar
• Ross R, Gillitzer C, Klein TR, et al. Involvement of NO in contact hypersensitivity. Inter Immunol. 1998;10:61–69.
   PubMed Web of Science ®Google Scholar
• Korkina L, Scordo MG, Deeva I, et al. The chemical defensive system in the pathobiology of idiopatic environment-associated diseases. Curr Drug Metab. 2009;10:914–931.
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni F, Capsoni F, et al. Drug-induced lupus erythematosus. Autoimmunity. 2005;38:507–518.
   PubMed Web of Science ®Google Scholar
• Karlson EW, Watts J, Signorovitch J, et al. Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project. Arthritis Rheum. 2007;56:244–254.
   PubMed Web of Science ®Google Scholar
• Kang TY, El-Sohemy A, Comelis MC, et al. Glutathione S-transferase genotype and risk of systemic lupus erythematosus in Koreans. Lupus. 2005;14:381–384.
   PubMed Web of Science ®Google Scholar
• Schallreuter KU, Bahadoran P, Picardo M, et al. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol. 2008;17:139–160.
   PubMed Web of Science ®Google Scholar
• Dammak I, Boudaya S, Ben Abdullah F, et al. Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int J Dermatol. 2009;48:476–80. Dell’Anna ML.
   PubMed Web of Science ®Google Scholar
• Dell’Anna F, Urbanelli S, Mastrofrancesco A, et al. Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell Res. 2003;16:553–559.
   PubMedGoogle Scholar
• Kostyuk VA, Potapovich AI, Cesareo E, et al. Dysfunction of glutathione S-transferase leads to excess 4-hydroxy-2-nonenal and H(2)O(2) and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients. Antioxid Redox Signal. 2010;13:607–620.
   PubMed Web of Science ®Google Scholar
• Uhm YK, Yoon SH, Kang IJ, et al. Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population. Life Sci. 2007;81:223–227.
   PubMed Web of Science ®Google Scholar
• Korkina LG, Pastore S, De Luca C, et al. Metabolism of plant polyphenols in the skin: beneficial versus deleterious effects. Curr Drug Metab. 2008;9:710–29.
   PubMed Web of Science ®Google Scholar
• Le Poole IC, van den Wijngaard RM, Smit NP, et al. Catechol-O-methyltransferase in vitiligo. Arch Dermatol Res. 1994;286:81–86.
   PubMed Web of Science ®Google Scholar
• Bolt HM, Their R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab. 2006;7:613–628.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2002;45:51–88.
   Web of Science ®Google Scholar
• Uchida K, Shiraishi M, Naito Y, et al. Activation of stress signaling pathways by the end product of lipid peroxidation. J Biol Chem. 1999;274:2234–2242.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang Y, Xu Y, et al. Endothelial glutathione- S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappa B translocation. Toxicol Appl Pharmacol. 2008;230:187–196.
   PubMed Web of Science ®Google Scholar
• Cho SG, Lee YH, Park HS, et al. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Bio Chem. 2001;276:12749–12755.
   PubMed Web of Science ®Google Scholar
• Cesareo E, Parker LJ, Pedersen JZ, et al. Nitrosylation of human glutathione transferase P1-1 with dinitrosyl diglutathionyl iron complex in vitro and in vivo. J Biol Chem. 2005;280:42172–42180.
   PubMed Web of Science ®Google Scholar
• Townsend DM, Findlay VL, Tew KD. Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol. 2005;401:287–307.
   PubMed Web of Science ®Google Scholar
• D’souza A, Kurien BT, Rodgers R, et al. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Gen. 2008;9:62.
   Web of Science ®Google Scholar
• Kurien BT, Hensley K, Bachmann M, et al. Oxidatively modified autoantigens in autoimmune diseases. Free Rad Biol Med. 2006;15:549–56.
   Web of Science ®Google Scholar